Insurance by BogdanovaThe Encyclopedia of Insurance and Risk Science

RESEARCH DOSSIER

Insurance Embedded Insurance Platform Governance

Abstract. Embedded insurance places insurance contracting, distribution, or enrollment within the transaction environment of a noninsurance product or service. The retail interface can unite the customer journey while separating underwriting capacity, product design, distribution authority, payment collection, data processing, and claims handling across different legal entities. This monograph examines the allocation of responsibility within that institutional arrangement through comparative legal interpretation, economic analysis, transaction tracing, and an evaluation of customer-outcome controls. The analysis draws on international supervisory standards, selected European Union and United Kingdom provisions, Washington State travel-insurance rules and an enacted future framework, Australian supervisory guidance, supervisory studies, and published economic research. It distinguishes distribution from technical enablement, product manufacture from configuration, the transfer of operational tasks from the retention of legal duties, and the evidence of a transaction from the evidence of a good consumer outcome. The central conclusion is that the accountability of a distributed insurance service depends on the correspondence among legal obligations, effective decision rights, information access, and practical remedial authority throughout the policy lifecycle. Illustrative responsibility assignments, failure scenarios, and quantitative indicators demonstrate why customer-facing convenience, high conversion, and technically successful API transactions cannot by themselves establish appropriate coverage or fair value. No new named theory is proposed; the contribution is a comparative institutional and operational synthesis.

Keywords: Embedded insurance; insurance distribution; platform governance; product oversight; outsourcing; market conduct; consumer outcomes; operational resilience; claims accountability; auditability.

Introduction

The institutional problem of embedded insurance begins with a separation between the location of the consumer's decision and the location of the institution responsible for providing insurance. A traveler purchases a ticket from a booking site; the site presents trip interruption cover; a specialist intermediary manages the offer; an insurer issues the policy; a service provider accepts claims. The purchaser experiences one transaction, while the contract and supporting services belong to a network of organizations. The resulting arrangement calls for a governance analysis that follows the insurance obligation beyond the checkout.

For this study, embedded insurance means the provision or arrangement of insurance coverage through the purchasing, membership, usage, or servicing environment of another good or service. The term identifies a distribution arrangement, not a universal legal category or a distinct actuarial class. An embedded product can be individually contracted or offered under a group arrangement, separately priced or included within a package, manually administered or integrated through application programming interfaces (APIs). Each feature changes the governance questions. Whether a particular firm is an insurer, intermediary, ancillary intermediary, policyholder, service provider, controller, or processor remains a question of the applicable law and actual functions.

The investigation asks who determines product terms and market access, who possesses the information required to identify customer harm, and who can correct a failed transaction. It also asks which features of the governance arrangement are portable across jurisdictions and which depend on a specific licensing, policyholder protection, or data regime. The unit of analysis is the insurance service chain attached to a defined product version, jurisdiction, and distribution path, not the technology company as an undifferentiated whole.

The methodology combines doctrinal comparison of selected legal provisions, analysis of institutional incentives, and prospective event tracing. International supervisory standards provide benchmarks; EU directives, regulations, and judicial decisions supply a legal comparison; UK sectoral rules illustrate product value and conduct mechanisms; Washington offers a state-level travel insurance example with a separate prospective statutory regime; Australia illustrates a temporal restriction on certain add-on insurance sales. Regulatory summaries are evidence of the reported studies or interventions, not substitutes for their underlying microdata. Academic articles support bounded propositions from their abstracts and selected passages; the study does not replicate their formal models or empirical estimates. Examples, responsibility matrices, and numerical values constructed by the author are analytical illustrations, not observed industry statistics. The study does not calculate the prevalence of embedded insurance or estimate the causal effect of an actual platform deployment.

The source hierarchy is important. Legislation and rules establish jurisdiction-specific obligations; judgments interpret particular legal questions; IAIS material supplies international supervisory benchmarks; supervisory studies describe findings in their investigated settings; and economic literature supplies mechanisms that may inform interpretation. The research date is November 19, 2026. Consolidated legal-text versions and rule dates are identified in the bibliography. A product-specific legal opinion would additionally require checking local legislation, subsequent amendments, contracts, regulatory authorizations, and the actual operating model.

The scope is cross-institution accountability, product oversight, platform interfaces, service agreements, delegated control, and remedial traceability. Detailed checkout-consent psychology and platform competition are adjacent research subjects; they appear here where they affect the allocation of responsibility.

Embedded Insurance Institutional Models

Distribution arrangements and the separation of functions

An embedded transaction may be organized as a referral, a delegated sale, co-manufactured insurance, a group enrollment, or a benefit bundled into the underlying service. These arrangements may look almost identical on a screen. Their significance arises from the things each participant is authorized to do and the contractual relationship established with the insured. A referral supplies access to another institution; delegated sale may involve arranging or concluding cover; a group policy can distribute rights and obligations among policyholder, insurer, and enrolled beneficiary; a technology vendor may transmit data without deciding the offer; and a commercial partner may exercise substantial influence over the product.

An institutional map must separate the party carrying insured risk from the parties controlling eligibility, wording, price, presentation, enrollment, money, and servicing. It must also distinguish the insured person, purchaser, group policyholder, and beneficiary. These roles can coincide but need not do so. An employer or merchant may be the contracting policyholder while the employee or customer has benefit rights. The question of who may terminate coverage, receive a refund, or request payment depends on the contract and applicable mandatory law.

The IAIS (2024) intermediary and conduct principles distinguish intermediation, introductions, and supplemental functions, and address conduct supervision of insurers and intermediaries. The analytical implication is that the public-facing brand cannot reliably identify the regulatory perimeter. A platform performing a strictly technical function and a platform determining which insurance contract a customer receives require different scrutiny even if they use the same interface template.

Functional comparison of arrangements

Illustrative arrangement Commercial interface Principal insurance decision Governance exposure
Referral Merchant directs customer to insurer Insurer or authorized intermediary Misleading introduction; incomplete transfer
Delegated distribution Platform or merchant offers cover in transaction Insurer sets terms; delegate executes authorized tasks Licensing, training, scripts, data quality
Joint product design Platform participates in essential design choices Insurer and qualifying co-manufacturer Decision rights, common target market, change approvals
Group enrollment Membership creates access to insured benefits Group policyholder and insurer within their roles Eligibility, status, certificates, continuity
Included benefit Cover comes with a purchased service Sponsor and insurer structure benefit Visibility, beneficiary rights, cancellation and financing

The table identifies investigatory questions rather than legal classifications. A referral may become distribution where the referring firm does more than transmit a prospect; a merchant may be an ancillary intermediary where its activities satisfy the applicable definition; and a group arrangement may engage distributor regulation. The relevant regulatory test is performed for each activity rather than the marketing label of the partnership.

Product flow and risk flow are also distinct. A technology platform can aggregate many customer journeys while the underwriting exposures remain with several insurers. Conversely, one insurer may accumulate similar exposures from different merchants through a common intermediary. Governance has to identify these two kinds of concentration independently. A common platform can create correlated operational interruptions even where underwriting risk is diversified.

Historical continuity and digital transformation

The economics of intermediary functions predates platform integration. Cummins and Doherty (2006), in their study of insurance intermediaries, analyze independent intermediaries in commercial property-casualty insurance. Their market setting differs from consumer checkout. The useful comparison is institutional: the role of an intermediary should be evaluated through the functions that it performs, including the value that its participation creates and the incentives accompanying its position.

EIOPA's (2024) digitalization survey findings show heterogeneous digital readiness and continued importance of physical and hybrid distribution. Embedded insurance should therefore be studied as one configuration within a changing market, not presented as an established replacement for every channel.

The digital difference is the speed and granularity with which delegated decisions are executed. A revised eligibility rule can change thousands of offers; a new translation can alter the customer's understanding; a temporary connectivity failure can affect enrollment. These changes are potentially observable and reversible through software governance, but only where the authorized organization has the ability and evidence to intervene. The architecture of decision authority matters more than the existence of an API.

Manufacturer-Distributor-Platform Responsibilities

Legal classification and actual decision rights

EU insurance distribution law illustrates the distinction between product manufacture and customer-facing distribution. The 2016 Insurance Distribution Directive (IDD), in its specified consolidation, covers a range of distribution activities and establishes conditions for an ancillary intermediary exemption. Article 1(4) retains safeguards when exempt ancillary intermediaries are used. Article 17 requires customer-oriented conduct and addresses conflicting incentive arrangements. Article 25 addresses product approval and distribution governance. These provisions require national implementation and applicable scope assessment; the label “embedded” does not answer either question.

The Commission's (2017) product oversight and governance regulation (POG), as consolidated in 2022, treats an insurance intermediary's substantive decision-making in product design as material to manufacturing status and calls for written allocation when both insurer and intermediary qualify as manufacturers. Ordinary adjustment within product options and autonomous decisions about essential features require different analysis. The identity of the legally relevant manufacturer cannot be inferred only from ownership of intellectual property, the source of premium income, or the brand displayed to the consumer.

An example clarifies the distinction. A marketplace may select between three approved deductibles already provided by an insurer. Alternatively, the marketplace may decide the insured events, exclusions, eligible customer population, premium structure, and benefit maximum while the insurer provides capacity and adopts those choices with minimal revision. The first scenario calls for scrutiny of delegated configuration and distribution; the second presents a stronger basis for examining co-manufacturer status where the relevant legal test applies. The difference is substantive decision authority, not the number of choices exposed in the API.

The Court of Justice's 2022 TC Medical Air Ambulance judgment notice (C-633/20) concerns remunerated offering of voluntary group-insurance membership. It demonstrates the potential relevance of distribution rules even where the arranging party is also a policyholder. The case is not a holding that every sponsored or automatic group benefit constitutes distribution. The scope, remuneration, voluntariness, activities, and national implementation must be examined.

Allocation across the policy lifecycle

The following matrix is an analytical example for an insurer, authorized distributor, customer-facing merchant, and technical service provider. It represents a governance design to be tested against actual law and agreements. It is not a statement that every role bears the same legal duties.

Function Primary operational owner in example Information and control required
Insurance wording and insured risk Insurer or applicable co-manufacturers Version history, underwriting basis, approval
Product and distribution strategy Manufacturer with distributor coordination Target market and distribution limits
Checkout design and placement Merchant and authorized distributor Approved content, review and emergency suspension
Eligibility and quotation execution Authorized entity; API vendor executes Rule version, inputs, exception route
Policy issuance Insurer or authorized delegate Binding authority, unique policy record
Premium collection and reconciliation Appointed collecting entity Settlement, reversals, discrepancy controls
Servicing and cancellation Contractually authorized service owner Identity verification, effective dates, notices
Claims decision and payment Insurer or authorized claims delegate Coverage terms, reasons, escalation and funds
Complaint and redress Responsible regulated firm(s) Access across all relevant partner systems
Technology resilience Each relevant entity and contracted vendor Incident evidence, recovery and continuity

Where multiple firms participate in one stage, governance requires a decision owner and an escalation route. Shared accountability cannot simply mean that every firm receives a copy of a report. It should mean that each legal or contractual obligation is paired with practical authority, sufficient evidence, and the ability to correct its own part of the service.

Contracts should separate authority to bind cover, permitted use of the insurer's name, distribution restrictions, data obligations, reporting intervals, change approval, claims and complaints responsibilities, validation rights, termination, and transition. They should also specify which decisions remain reserved to a regulated firm. A contractual indemnity may transfer certain costs between firms; it does not itself erase obligations owed to insured persons or supervisors.

Compensation, conflict, and oversight

The FCA's (2019) distribution chain review investigated the value chain and controls in delegated authority arrangements. EIOPA's (2022) credit protection insurance warning highlighted remuneration and conflict concerns for insurers and bank distributors. These are historical and sector-specific primary supervisory observations, not estimates of risk across current API-based platforms.

Their significance for this study is a mechanism: the commercial participant controlling access to a customer can negotiate remuneration while another participant bears insurance obligations. Commission, per-enrollment payments, advertising placement, administrative charges, and profit shares may respond to different performance objectives. Remuneration attached exclusively to acquisition can make the acquisition team sensitive to conversion and less sensitive to later service quality. A compensation committee should therefore examine the economic substance of the entire payment chain, the cost of genuine services, and the consequences of the incentive structure for customers.

A governance review can ask whether compensation changes when the distributor moves a customer outside the intended segment; whether claim refusal affects an intermediary's reward; whether refund costs create resistance to cancellation; and whether a platform may vary sorting order for commercial reasons. The resulting evidence belongs with the product decision. A large commercial payment is a signal requiring explanation, not conclusive proof of poor value. An inexpensive channel is similarly not proof of appropriate coverage.

API Integration and Outsourcing Controls

The difference between an API response and insurance effect

An API transmits a representation of a transaction. The insurance effect depends on the authorized actions and legal arrangements behind that representation. In a typical sequence, an underlying transaction triggers an eligibility request, an insurance offer is generated, the customer action is captured, the distributor transmits an enrollment or binding instruction, the authoritative system records the policy state, and the customer receives confirmation.

The system should identify the transaction and policy separately. An order may contain more than one insured interest, and one policy may relate to several orders or members. The message identifier records a technical event; the policy identifier records the contractual object or administrative representation of that object. A merchant's order completion is therefore an inadequate substitute for proof that cover was legally arranged.

Consider a timeout after a binding request. The platform cannot determine from silence whether the insurer processed the request. An automatic retry without a stable idempotency identifier can produce duplicate policies or premiums; a failure screen can incorrectly imply that coverage does not exist. The governance design should specify authoritative status retrieval, duplicate detection, reconciliation, and a customer communication path for ambiguous states. Processing the same intent repeatedly should not create new cover unless that action is explicitly intended and authorized.

A useful operational record contains the merchant transaction identifier, insurance offer identifier, authoritative product and wording version, timestamp and timezone, jurisdiction and currency, material eligibility inputs, decision response, customer action, binding instruction and acknowledgement, collection state, and later corrections. Privacy rules and retention limits constrain what may be recorded. The goal is reconstructability with minimum necessary personal data, not comprehensive behavioral surveillance.

Delegated services, resilience, and authority

The EU's 2022 Digital Operational Resilience Act (DORA), applicable from January 17, 2025, addresses ICT risk and third-party arrangements for covered financial entities. Article 28 preserves the financial entity's regulatory responsibility; Articles 29 and 30 address dependencies and contractual arrangements. Applicability depends on entity type and relevant exclusions. A commercial platform or API connection does not automatically constitute the same regulated relationship in each case.

An assessment of the criticality of a service should consider what the service does to existing policies. If a pricing service fails, new quotations may be suspended while in-force claims continue. If an outsourced policy register fails and the insurer cannot determine existing coverage, the implications are more extensive. A shared cloud dependency may affect apparently separate platforms. A meaningful dependency register includes material subcontractors and service geography to the extent needed for oversight.

A service agreement should address availability, recovery, incident reporting, evidence access, change notifications and testing, secure export, termination assistance, and data return or deletion. Its controls must be usable in practice. An audit right that requires several months of notice during an unfolding incident provides little immediate visibility; an exit plan that exports raw data without the meaning of its fields fails to show that obligations can be transferred. Tests should demonstrate usable restoration of covered records and essential services, not only creation of backup files.

Failure responses need to respect the different legal states of the customer relationship. Suspending new offers after a material incident can be appropriate, while deleting existing policy information or making claims inaccessible is an additional source of harm. An insurer or distributor must determine what existing customers were promised and how that commitment remains serviceable after a merchant partnership ends.

Data roles and model-based decisioning

Under the EU's 2016 General Data Protection Regulation (GDPR), actual determination of processing purposes and means matters to controller status; Articles 26 and 28 distinguish joint controller arrangements and processor relationships. Separate insurance and merchant activities may have different legal bases and data responsibilities, and the relationship can change across stages.

The insurer may need destination, trip duration, age category, and covered amount; the merchant may possess a broader behavioral profile. Sharing the full merchant profile simply because it is technically available increases exposure and may conflict with applicable purpose or data-minimization requirements. A governance map should identify what each attribute is used for, who may change the purpose, where it is retained, and which party responds to relevant rights requests.

Automated offer ranking and eligibility decisions require change control. The model or ruleset version used at the time of a decision should be recoverable under a legitimate retention basis. Testing should consider boundary cases and the effect of missing data, as well as systematic differences in access or outcomes. A monitoring alert may identify an association between a customer characteristic and rejection; additional investigation is needed to establish whether the disparity is attributable to legitimate risk classification, data quality, distribution choices, or an unlawful or unfair factor. This monograph does not establish a universal protected-class test or a particular AI regulation's applicability.

Product Oversight and Customer Journey Interfaces

From an approved product to an approved channel

Product governance is concerned with the product that customers actually encounter. A well-designed insurance contract can generate foreseeable problems when sold through an unsuitable context or to a population for which it provides little useful protection. Conversely, an interface can be transparent while the coverage has structural weaknesses. The manufacturer and distributor therefore need a common account of the product's intended benefits, exclusions, eligible population, and method of sale.

The EU POG regulation (European Commission, 2017, Arts. 5–11) connects product approval and review to the target market, distribution arrangements, information exchange, and documentation. A manufacturer should be able to observe whether an approved distribution strategy is implemented. The distributor must have adequate product understanding within the relevant scope. A distribution partner with authority to optimize an offer should not receive unrestricted permission to change the product's market, wording, or material presentation.

In the UK, applicable non-investment insurance products are governed by the FCA's PROD 4 rules, including fair-value assessment and consideration of distribution effects. The broader Consumer Duty has a distinct applicability architecture. The FCA's PRIN 2A provisions expressly exclude defined non-investment and legacy non-investment insurance products from the PRIN 2A.4 price-and-value rules under 2A.4.32; applicable PROD requirements remain relevant. A reviewer should map the actual product and obligation, rather than count the same economic assessment as two independent legal requirements.

The operational question is whether the channel may change the relation between approved and realized product value. A travel policy covering cancellation for specified reasons may be displayed beside a ticket marketed as flexible. Some users may already hold overlapping coverage; others may have an itinerary excluded by the product. A device protection product may offer a valuable repair benefit, yet duplication of a statutory guarantee or manufacturer warranty may alter the value of the incremental cover. These issues require product-specific analysis rather than categorical rejection of embedded offers.

Interface as a controlled distribution instrument

The product approval record should be linked to the interface release process. Marketing text, display order, translations, eligibility prompts, exclusions summaries, timing, pricing, comparison options, and communication of the insurer's identity can all affect customer understanding. A change in the surrounding transaction can have the same effect as a change in the insurance widget. An insurer's approval of the widget in isolation cannot establish that the overall customer journey remains suitable.

An interface test should use actual permutations: mobile and desktop, different available languages, accessibility settings, guest checkout, logged-in purchase, primary service cancellation, payment failure, and repeat ordering. The reviewer needs a controlled view of the information that appeared before the customer's election. A static screenshot supplied at launch is inadequate if different customers see substantially different offers. Versioned templates and privacy-preserving reconstruction can support audit without storing complete recordings of personal sessions.

An experiment that changes the presentation of insurance should have acceptance criteria beyond commercial conversion. Eligible participation, coverage understanding, complaint rates, cancellations, and later claims use can help reveal differences between variants. Where a variant materially changes the nature of the offer or likely audience, the governance team should first determine whether product and distribution approval must be revisited.

Economic evidence about add-on choice

Gabaix and Laibson's (2006) shrouded attributes analysis presents an economic setting in which some consumers' limited attention permits concealment of add-on costs. Its applicability to insurance is an analytical analogy, given the different goods and assumptions in the theoretical work. It suggests an investigatory question: how much of the cost and scope of insurance becomes visible when consumers are comparing the primary product, and how much is encountered after they have already invested attention or effort?

The FCA's (2014) general insurance add-ons study supplies sector-specific historical evidence about poor-value and ill-matched purchases in the UK add-on market. Its behavioral experiment summary reports weaker comparative shopping in a simulated add-on purchasing environment. These sources support examination of transaction context as a potential influence on choice. They do not establish a universal reduction in welfare for every embedded product, and their results do not measure the effect of a modern platform's particular design.

A reasonable interpretation is that integration reduces both useful search costs and opportunities for comparison. Which effect dominates depends on the product, how consumers value their time, whether independent alternatives are visible, the consequences of inadequate protection, and the degree of information asymmetry. Convenience is one element of consumer value; it should be measured alongside price, benefits, restrictions, and post-sale access.

Cross-Border Platform Regulation

Jurisdiction and the functional perimeter

A globally accessible interface can offer a service in multiple territories, while an insurance contract remains embedded within specific legal regimes. The seller's incorporation, the insurer's authorization, the location of the insured risk, the customer's residence, the distribution activity, the contract's governing law, and the location of data or operational processes can be different. No single factual variable establishes every jurisdictional obligation.

A cross-border rollout should identify regulated activities and entities for each product and target jurisdiction. The legal inventory should distinguish the insurance authorization, distribution permission or exemption, applicable policy and consumer rules, payment and tax treatment, and information-processing obligations. The data plan and operational plan should follow the resulting allocation rather than use the location of a platform's headquarters as a global default.

The EU distribution directive provides a common structure with local implementation, including conditional ancillary treatment and complaints and redress provisions. A platform that relies on an exemption should preserve evidence that the product, activity, and transaction satisfy its conditions. It should also document what safeguards remain applicable to other parties. The exemption analysis is product-and-activity specific, and changes in the underlying service or coverage may invalidate the initial assessment.

The IAIS conduct supervision benchmark recognizes variation among national supervisory regimes and the need for coordination. It supplies a basis for comparison, rather than a cross-border authorization mechanism. A global policy document can reflect its general aims, but the institution requires local controls capable of satisfying the applicable national rule.

State-level illustration and the time dimension

The United States presents state-specific questions of producer licensing and travel insurance distribution. The Washington limited-line travel insurance rule offers an existing regulatory example of licensing and supervised retailer participation. The official rule, as amended effective November 1, 2024, identifies producer authorization, retailer registration, training, supervision, and producer responsibility for retailer acts. Its role allocation illustrates how distribution through a retailer can remain subject to oversight by an authorized insurance producer.

Washington's enacted 2026 Travel Insurance Act (Chapter 48.216 RCW) provides a more detailed prospective comparison. Sections 1–13 of chapter 165 take effect January 1, 2027. Consequently this future chapter is not treated as operative law on the research date. Its provisions describe a registered travel-retailer channel under a limited-lines producer, with training, disclosure, restrictions on technical insurance advice, and responsibility for supervised activities. The example concerns travel insurance in Washington; it establishes neither a general federal platform rule nor a nationwide exemption.

Australia illustrates a different regulatory mechanism. The Australian Securities and Investments Commission (ASIC, 2021) explains in its deferred sales guidance (RG 275.47–52) that the deferral period for covered add-on insurance begins when the customer commits to the principal product or service and receives the prescribed customer information. It ends after four subsequent days, and a sale cannot be irrevocably arranged during that interval merely by postponing issuance. The guide recognizes statutory exceptions and regulatory exemptions; it does not prohibit every embedded insurance transaction. For platform governance, the implication is that timestamped records must distinguish principal-product commitment, delivery of the prescribed information, a permitted subsequent sale, and any applicable exemption. A checkout event by itself cannot establish that this sequence occurred. The timing rule also demonstrates why changing technical issuance alone may leave the legally relevant sales event unchanged.

The temporal separation matters operationally. A platform preparing for the future regime may incorporate the prospective requirements in a test environment and contract transition plan. Its production compliance decision before the effective date must rely on the rules then in force. Date-specific evidence should tie the control, jurisdiction, legal version, and rollout period together. A registry that contains only the latest text can otherwise create the inaccurate impression that a new duty governed earlier sales.

Comparative governance implications

Jurisdiction or institution Instrument examined Governance implication Limit
International IAIS ICP 18 and 19 Supervision of intermediation and fair treatment Benchmark; domestic implementation varies
European Union IDD and POG Activity and manufacturer classification; lifecycle governance National implementation and scope
European Union DORA and GDPR ICT dependency and processing-role allocation Covered entities, activities, legal basis
United Kingdom PROD 4, PRIN 2A, ICOBS Sectoral value, applicable duty and sales/claims controls Product and firm applicability
Washington State Existing WAC; enacted Chapter 48.216 Travel-specific producer and retailer oversight State and product scope; new act future-effective
Australia ASIC Regulatory Guide 275 Separation in time of principal purchase and add-on insurance sale Subject to statutory scope and exemptions

The comparison supports limited convergence in the questions that regulators and firms need to ask: who performs the activity, who directs the product, what conflicts arise, how customers receive information, what evidence exists, and who corrects failures. The answers remain jurisdictionally specific. This study does not claim exhaustive international coverage or equivalence among the instruments.

A practical cross-border risk arises when a global product team controls a shared interface while local entities are accountable to different regulators. Local compliance teams need the power to stop distribution, branch the interface or change coverage disclosures within approved procedures, and obtain event-level information. The global team requires a mechanism for identifying changes that have cross-market consequences. A centrally approved design is useful only where jurisdictional restrictions are transmitted into executable controls and exceptions are monitored.

Auditability and Consumer Outcome Evaluation

An auditable chain of responsibility

The audit subject is the path connecting the product approval decision to a specific customer outcome. An operational audit, conducted against the actual contracts and authorization matrix, should sample both ordinary and exceptional cases. Each test identifies the recorded event, the responsible actor, the policy or transaction version, the permitted action, expected consequence, observed consequence, and any remediation.

For a sampled offer, the reviewer can examine whether the displayed product and eligibility criteria corresponded to the approved version. For an enrollment, the reviewer can compare collection information with the policy register and required evidence of customer election. For a claim, the reviewer can compare the authoritative policy terms, intake event, assigned handler, decision reasons and payment or closure. For a complaint, the reviewer can trace the original receipt time, forwarding, decision, remedy, and feedback. This procedure applies familiar audit and process-tracing techniques; it is not a new governance doctrine.

In the illustrative design, the insurer's policy register is authoritative for recorded coverage states. Merchant systems provide transaction context; intermediary systems provide distribution evidence; claims systems provide outcomes. Where records disagree, the appropriate treatment requires checking legal effect, delegated authority, message history, and the contract. An authoritative system can contain an error. The purpose of reconciliation is to establish and correct discrepancies, not to assume that whichever database the insurer operates is infallible.

Testing should include injected failures in an isolated environment. An example is duplicate delivery of a binding instruction, followed by an insurer timeout and later confirmation. Expected results include duplicate suppression, status reconciliation, clear consumer messaging and an escalation path if ambiguity remains. A separate test covers loss of the merchant connection with an in-force policy; the expected result is continued access to the relevant servicing and claims channels. The scenarios are proposals; no actual platform was tested in this research.

Measures and denominator discipline

Customer outcomes require measurements that preserve the population and time period to which they refer. The FCA's (2025) 2024 value measures commentary describes several useful claims-related indicators. These provide a measurement precedent, not a universal regulatory threshold. A platform-level evaluation should define comparable cohorts by product version, period, jurisdiction, exposure, and maturity.

Illustrative measure Numerator Denominator Main limitation
Offer transmission failure rate Eligible offer attempts with technical failure Eligible offer attempts Repeated attempts and deduplication
Confirmed issuance rate Distinct issued policies Distinct accepted valid offers Timing, pending and withdrawn offers
Claims frequency Defined reported claim count Earned exposure or policies in scope Claim and exposure definitions
Claims acceptance rate Accepted or partly accepted resolved claims, as defined Resolved claims in same cohort Open cases, withdrawals and treatment of partial claims
Claims complaint rate Identified claim-related complaints Claims in the stated population Underreporting and classification
Refund completion rate Refunds completed by cutoff Refunds due by relevant cutoff Pending entitlements and reversals
Target-market exception rate Reviewed sales outside approved criteria Reviewed sales with determinable criteria Missing data and sampling

These are suggested operational definitions, not a representation of the exact FCA reporting taxonomy. Ratios should be disaggregated by relevant subpopulation and compared against documented baselines. A zero denominator produces an undefined rate, not zero. Missing observations and excluded unresolved cases should be disclosed; the use of a small denominator should prompt uncertainty reporting.

Suppose an illustrative monthly channel records 10,000 distinct valid accepted offers, 9,850 confirmed issuances, 100 pending acknowledgements, and 50 failed or otherwise nonissued offers. At the cutoff the confirmed issuance rate is 98.5%. The pending cases constitute 1% of accepted offers, and the confirmed nonissuance rate is 0.5%. Treating the entire remaining 1.5% as definitive failure would overstate the known failure rate. Treating all accepted offers as policies would conceal both categories. A later cutoff should reconcile transitions without silently changing the original snapshot.

In a separate illustrative mature claims cohort, 180 out of 200 resolved claims are classified as accepted, giving a 90% rate. If another 100 claims remain open, 180 of 300 is 60%, but this latter figure describes accepted claims among all reported claims at the cutoff, not the acceptance rate among resolved claims. The distinction is especially relevant where complicated claims take longer to resolve. A rising share of pending claims can improve the resolved acceptance rate while damaging accessibility or timeliness.

A financial decomposition can distinguish consumer-paid insurance price from risk cost and service contributions. Suppose an illustrative $100 separately priced premium supports $55 of expected claims, $15 of distribution remuneration, $20 of other administration and risk-related costs, and $10 of residual margin, ignoring taxes, timing, investment effects and reinsurance for simplicity. These components sum to $100. The example is neither an insurer accounting statement nor a fair-value determination. It supplies questions: whether the $15 remuneration reflects useful services, whether overlapping benefits reduce incremental value, and whether the claim cost estimates are credible.

Claims ratios can be distorted by mismatched flows. The FCA's 2024 value-measures publication describes how intervention-related sales reductions in GAP insurance coincided with claims costs above contemporaneous written premium. That example illustrates the danger of interpreting a single period's ratio as a stable product value measure. Earned exposure, timing, claim development, and changes in the business mix matter. FCA's 2025 value measures commentary also records retrospective correction of two aggregate 2024 data points, reinforcing the need for versioned statistical series.

Causal interpretation and oversight responses

A before-and-after comparison of platform interfaces is vulnerable to changes in customer mix, underlying transaction prices, season, insurer capacity, and benefit design. A simple difference between embedded and stand-alone channels may reflect self-selection. Evaluation should compare the same product and definitions where feasible, allow for exposure and claim maturity, record confounders, and avoid interpreting a descriptive difference as a treatment effect.

If random assignment of lawful, approved interface variants is possible, assignment and analysis should preserve ethical safeguards and a clear unit of randomization. Customer understanding and behavior may be measured near purchase; claims outcomes require an appropriate observation horizon. Where randomization is infeasible, matched comparisons or quasi-experimental designs can be considered, but their assumptions must be stated and tested where possible. This monograph proposes no estimated causal effect and presents no field experiment.

Escalation should be proportionate to the observed defect and available evidence. A data mismatch may require reconciliation and revised monitoring. A suspected mis-sale affecting multiple customers may require suspension of the relevant distribution path while facts are established. A systemic breakdown in the claims channel may require alternative intake, customer outreach, and review of accumulated cases. The reviewer should record the evidence supporting each action and the basis for closing it, along with any remaining uncertainty.

The original analytical contribution is to connect responsibility mapping with outcome evidence across the lifecycle. A control has limited value when it monitors an event that the responsible entity cannot interpret or change; conversely, sweeping contractual rights without reliable data prevent informed exercise of authority. The congruence between decision rights, evidence, and remedial capacity is the practical criterion emerging from the comparison. It is a synthesis of existing institutional, regulatory, and operational reasoning, not a claimed novel scientific theory.

Conclusion

Embedded insurance integrates insurance access into another transaction while distributing insurance functions among organizations. Its governance is determined by the functions performed, the applicable law, the contractual authority actually granted, and the practical ability to deliver and correct the promised service. The study's first research question is answered by functional classification and an explicit lifecycle assignment of decision rights. The risk carrier, manufacturer, distributor, merchant and technology provider may occupy overlapping roles, and responsibility must be established activity by activity.

The second question concerns verifiable accountability across financial, information and service pathways. A reliable governance arrangement connects the approved product and interface to the customer's actual offer and policy state, maintains reconciliation of money and status, preserves access to claims and complaints, and can identify and remedy previously affected customers. Event records are important insofar as they establish a decision and its consequences. Their preservation is constrained by legitimate processing purposes and retention obligations.

The third question concerns comparison across regulatory regimes. International supervisory benchmarks, EU functional definitions and product governance, UK sectoral value and conduct rules, the Washington travel-insurance example, and Australia's deferred-sales guidance exhibit common investigatory concerns while retaining different definitions, scopes, and effective dates. Cross-border oversight therefore benefits from common operational evidence and separate local legal assessment. The future Washington chapter is explicitly distinguished from operative law on the research date.

Customer outcomes need independent assessment because successful API execution, high conversion, low complaints and even a favorable isolated claims ratio may be misleading in the absence of suitable denominators, cohort maturity and information about consumer needs. Supervised access to operational data, meaningful audit rights and tested remediation are essential means of connecting an institutional duty to the customer experience.

The study is comparative and documentary. It supplies illustrative operational controls and computations rather than proprietary data, field audit results, economic effect estimates or a complete legal inventory. The comparison relies on selected provisions, published studies, and documented regulatory guidance; it does not cover every national market or reproduce all empirical analyses in the cited literature. Further investigation could examine matched channel cohorts, effective state and national licensing frameworks, platform service interruption data and the effectiveness of retrospective remedies. The established conclusion is that an embedded insurance arrangement should be evaluated over the lifetime of the insured relationship, including the period after the originating commercial relationship ends.

References